Full name
ROCHE DIABETES CARE POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
33.12.Z - Repair and maintenance of machinery
33.13.Z - Repair and maintenance of electronic and optical devices
46.51.Z - Wholesale trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
72.19.Z - Scientific research and development activities
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
85.60.Z - Educational support activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 4,5 | 5,6 | 10,1 | 81,2 |
EBITDA | 4,3 | 3,8 | 7,1 | 84,9 |
Short time liabilities | 25,9 | 44 | 33,1 | -24,7 |
Equity capital | 43,1 | 47,4 | 55,5 | 17 |
Operating profit (EBIT) | 4,4 | 3,9 | 7,1 | 82,8 |
Assets | 78,5 | 100,7 | 94,2 | -6,4 |
Net profit (loss) | 3,4 | 4,3 | 8,1 | 86,2 |
Cash | 0 | 0 | 0,1 | 4216,6 |
Net income from sale | 171 | 179,6 | 176,3 | -1,8 |
Liabilities and provisions for liabilities | 35,4 | 53,3 | 38,8 | -27,3 |
Working assets | 76,3 | 98,5 | 93 | -5,5 |
Depreciation | -0,1 | -0,1 | -0 | 36,9 |
% | % | % | p.p. | |
Profitability of capital | 7,9 | 9,1 | 14,5 | 5,4 |
Equity capital to total assets | 54,9 | 47,1 | 58,8 | 11,7 |
Gross profit margin | 2,6 | 3,1 | 5,7 | 2,6 |
EBITDA Margin | 2,5 | 2,1 | 4 | 1,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 55 | 89 | 69 | -20 |
Current financial liquidity indicator | 2.516803741455078 | 2.0438945293426514 | 2.6272027492523193 | 0,6 |
Net dept to EBITDA | -0.006165676284581423 | -0.0008482664125040174 | -0.01979820430278778 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane